Ask Warren

Cellumed

049180 · KOSDAQ · ₩049180 · 셀루메드

₩1,009 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩31B₩23B₩28B₩37B₩35B₩39B₩37B₩33B
Cost of sales₩27B₩22B₩26B₩33B₩38B₩37B₩35B₩31B
Gross profit₩4.1B₩1.6B₩2.4B₩4.5B−₩2.2B₩1.9B₩2.1B₩2.3B
Operating income₩1.6B−₩1.6B−₩649M₩1.4B−₩4.3B−₩1.6B−₩3.4B−₩1.2B
Net income₩4.3B−₩1.7B−₩10B₩11B−₩1.1B−₩1.4B−₩30B₩773M
Net income to shareholders₩2.6B−₩1.7B−₩6.2B₩8B−₩2.5B−₩1.5B−₩25B−₩2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩72B₩69B₩61B₩72B₩75B₩75B₩70B₩76B
Current assets₩60B₩53B₩45B₩55B₩58B₩60B₩52B₩54B
Cash and equivalents₩4.1B₩16B₩7B₩3.6B₩5.6B₩6.9B₩9.6B₩4.3B
Total liabilities₩47B₩45B₩53B₩55B₩66B₩62B₩61B₩43B
Current liabilities₩45B₩43B₩51B₩53B₩64B₩60B₩58B₩39B
Borrowings₩8.4B₩10B₩13B₩11B₩13B₩7.3B₩8.8B₩9.1B
Total equity₩25B₩24B₩8.4B₩17B₩8.5B₩13B₩9.1B₩33B
Shareholders' equity₩25B₩24B₩8.4B₩16B₩8.3B₩12B₩8.8B₩32B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.3B−₩6.3B₩1.6B−₩295M−₩1.4B−₩3.8B₩1.4B−₩3.4B
Capital spending₩113M₩14M₩30M₩44M−₩6.4M₩219M₩273M₩780M
Free cash flow₩1.2B−₩6.3B₩1.6B−₩339M−₩1.4B−₩4B₩1.1B−₩4.2B

Consolidated where available. Amounts in won.

Also known as: Cellumed / 셀루메드 / 049180 / KRX:049180

Source: KRX statistical information